Ryan Cross

Ryan Cross

scienceboss.bsky.social

Senior Science Correspondent at Endpoints News. Reach out privately on Signal: RyanCross.25

👤 Joined on 19 February 2025

94

Followers

26

Following

217

Total Posts

📜 Kullanıcı Geçmişi

  • 19 Şub 2025, 14:48
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @scienceboss.bsky.social

🚫 Blokladığı Kullanıcılar

❤️ Beğendiği Gönderiler

HUGE loss, both as a friend and a journalist. She was the GOAT. 😢 www.statnews.com/2026/10/13/h...

Show Post
Endpoints News
25 September 2026 15:23

After 150 nominations, months of research and debate, 11 startups made the cut, with work spanning gene therapy, CAR-T, longevity, AI and robotics. Meet the 2026 Endpoints 11:

Show Post

I appreciate this measured article on a challenging and divisive area of science by @scienceboss.bsky.social. There is far too much uncritical reporting of wild and irresponsible claims by fringe players looking for attention.

Show Post
Endpoints News
10 March 2026 20:09

Exclusive: RNA editing startup Tacit Therapeutics has launched with $19M to develop therapies for brain diseases, starting with Huntington’s.

Show Post

I'm late, but don't miss this piece from @scienceboss.bsky.social: Gene editing's search for a 'holy grail' has led to an explosion of tools, but few cures Via @endpts.com endpoints.news/as-gene-edit...

Show Post

Select language

Install App

Install App